University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: Biogen Direct, Cambridge, MA
Amount: An estimated $950,000
An estimated start date of 11/6/2018 through 2/1/2019
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Monday, November 12, 2018
The University awarded a contract for Tecfidera.
Tecfidera (dimethyl fumarate) is an oral medication used to treat relapse-remitting multiple sclerosis (RRMS).
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Biogen Direct is the exclusive distributor of Tecfidera and without its purchase, patient care and revenue could be compromised.
For additional information, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.